JP2019508504A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019508504A5 JP2019508504A5 JP2018567029A JP2018567029A JP2019508504A5 JP 2019508504 A5 JP2019508504 A5 JP 2019508504A5 JP 2018567029 A JP2018567029 A JP 2018567029A JP 2018567029 A JP2018567029 A JP 2018567029A JP 2019508504 A5 JP2019508504 A5 JP 2019508504A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- pyran
- tetrahydro
- hydroxymethyl
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003118 aryl group Chemical group 0.000 claims 47
- 125000001072 heteroaryl group Chemical group 0.000 claims 44
- 125000000217 alkyl group Chemical group 0.000 claims 41
- 229910052739 hydrogen Inorganic materials 0.000 claims 33
- 239000001257 hydrogen Substances 0.000 claims 32
- 125000003710 aryl alkyl group Chemical group 0.000 claims 27
- 150000001875 compounds Chemical class 0.000 claims 26
- 150000002431 hydrogen Chemical class 0.000 claims 26
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 21
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 20
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 20
- 125000000753 cycloalkyl group Chemical group 0.000 claims 18
- 125000004475 heteroaralkyl group Chemical group 0.000 claims 18
- 125000005843 halogen group Chemical group 0.000 claims 17
- 125000003545 alkoxy group Chemical group 0.000 claims 16
- 125000001188 haloalkyl group Chemical group 0.000 claims 16
- 125000003342 alkenyl group Chemical group 0.000 claims 12
- 125000000304 alkynyl group Chemical group 0.000 claims 12
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 11
- 125000004663 dialkyl amino group Chemical group 0.000 claims 10
- 125000003282 alkyl amino group Chemical group 0.000 claims 9
- 150000003839 salts Chemical class 0.000 claims 8
- IYZIARNSXPGYSC-UHFFFAOYSA-N 3-phenylbenzamide Chemical compound NC(=O)C1=CC=CC(C=2C=CC=CC=2)=C1 IYZIARNSXPGYSC-UHFFFAOYSA-N 0.000 claims 7
- 239000008194 pharmaceutical composition Substances 0.000 claims 7
- WEEKAOKOZHZDMG-UHFFFAOYSA-N 5-phenylbenzene-1,3-dicarboxamide Chemical compound NC(=O)C1=CC(C(N)=O)=CC(C=2C=CC=CC=2)=C1 WEEKAOKOZHZDMG-UHFFFAOYSA-N 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 6
- -1 Here Chemical group 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 125000000623 heterocyclic group Chemical group 0.000 claims 4
- UGCSPKPEHQEOSR-UHFFFAOYSA-N 1,1,2,2-tetrachloro-1,2-difluoroethane Chemical compound FC(Cl)(Cl)C(F)(Cl)Cl UGCSPKPEHQEOSR-UHFFFAOYSA-N 0.000 claims 3
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims 3
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- 208000019206 urinary tract infection Diseases 0.000 claims 3
- NMJQBLVCTWZTJG-UHFFFAOYSA-M 1,2-dimethyl-1-[3-(2-methylphenoxy)-3-phenylpropyl]piperidin-1-ium;bromide Chemical compound [Br-].CC1CCCC[N+]1(C)CCC(C=1C=CC=CC=1)OC1=CC=CC=C1C NMJQBLVCTWZTJG-UHFFFAOYSA-M 0.000 claims 2
- LZPWAYBEOJRFAX-UHFFFAOYSA-N 4,4,5,5-tetramethyl-1,3,2$l^{2}-dioxaborolane Chemical group CC1(C)O[B]OC1(C)C LZPWAYBEOJRFAX-UHFFFAOYSA-N 0.000 claims 2
- 101100516563 Caenorhabditis elegans nhr-6 gene Proteins 0.000 claims 2
- 208000011231 Crohn disease Diseases 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 2
- 150000001345 alkine derivatives Chemical class 0.000 claims 2
- 125000004104 aryloxy group Chemical group 0.000 claims 2
- 150000001540 azides Chemical class 0.000 claims 2
- ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical group OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 150000002148 esters Chemical class 0.000 claims 2
- 125000005842 heteroatom Chemical group 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 125000004043 oxo group Chemical group O=* 0.000 claims 2
- 125000002827 triflate group Chemical group FC(S(=O)(=O)O*)(F)F 0.000 claims 2
- XPZSDHMMMWNMFP-LAAXVVMPSA-N (2R,3S,4S,5S,6R)-2-(hydroxymethyl)-6-[(R)-hydroxy-(2-methyl-4-quinolin-6-ylphenyl)methyl]oxane-3,4,5-triol Chemical compound O[C@@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)C1=C(C=C(C=C1)C=1C=C2C=CC=NC2=CC=1)C XPZSDHMMMWNMFP-LAAXVVMPSA-N 0.000 claims 1
- HROYAQPYJZZQRG-LAAXVVMPSA-N (2R,3S,4S,5S,6R)-2-(hydroxymethyl)-6-[(R)-hydroxy-(2-methyl-4-quinolin-7-ylphenyl)methyl]oxane-3,4,5-triol Chemical compound O[C@@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)C1=C(C=C(C=C1)C1=CC=C2C=CC=NC2=C1)C HROYAQPYJZZQRG-LAAXVVMPSA-N 0.000 claims 1
- IHBXHVLDHSEPAI-WVYLNQBTSA-N (2R,3S,4S,5S,6R)-2-(hydroxymethyl)-6-[(R)-hydroxy-[2-methyl-4-(2-methyl-3,4-dihydro-1H-isoquinolin-5-yl)phenyl]methyl]oxane-3,4,5-triol Chemical compound O[C@@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)C1=C(C=C(C=C1)C1=C2CCN(CC2=CC=C1)C)C IHBXHVLDHSEPAI-WVYLNQBTSA-N 0.000 claims 1
- STQUUJZLVQDZSK-YKHMXAMPSA-N (2R,3S,4S,5S,6R)-2-(hydroxymethyl)-6-[(R)-hydroxy-[2-methyl-4-(2-morpholin-4-ylpyridin-4-yl)phenyl]methyl]oxane-3,4,5-triol Chemical compound O[C@@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)C1=C(C=C(C=C1)C1=CC(=NC=C1)N1CCOCC1)C STQUUJZLVQDZSK-YKHMXAMPSA-N 0.000 claims 1
- AMMJPYNBCADPFP-YGBDOONVSA-N (2R,3S,4S,5S,6R)-2-(hydroxymethyl)-6-[(R)-hydroxy-[2-methyl-4-(3-methyl-1,2-benzoxazol-5-yl)phenyl]methyl]oxane-3,4,5-triol Chemical compound O[C@@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)C1=C(C=C(C=C1)C=1C=CC2=C(C(=NO2)C)C=1)C AMMJPYNBCADPFP-YGBDOONVSA-N 0.000 claims 1
- BMUUMLJVRXHVIV-YGBDOONVSA-N (2R,3S,4S,5S,6R)-2-(hydroxymethyl)-6-[(R)-hydroxy-[2-methyl-4-(3-methyl-2H-indazol-5-yl)phenyl]methyl]oxane-3,4,5-triol Chemical compound O[C@@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)C1=C(C=C(C=C1)C=1C=C2C(=NNC2=CC=1)C)C BMUUMLJVRXHVIV-YGBDOONVSA-N 0.000 claims 1
- XSFZSQNXQYGNSO-YGBDOONVSA-N (2R,3S,4S,5S,6R)-2-(hydroxymethyl)-6-[(R)-hydroxy-[2-methyl-4-(3-methylbenzimidazol-5-yl)phenyl]methyl]oxane-3,4,5-triol Chemical compound O[C@@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)C1=C(C=C(C=C1)C1=CC2=C(N=CN2C)C=C1)C XSFZSQNXQYGNSO-YGBDOONVSA-N 0.000 claims 1
- PEAHOTHJNQUEHV-YGBDOONVSA-N (2R,3S,4S,5S,6R)-2-(hydroxymethyl)-6-[(R)-hydroxy-[2-methyl-4-(4-phenyltriazol-1-yl)phenyl]methyl]oxane-3,4,5-triol Chemical compound O[C@@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)C1=C(C=C(C=C1)N1N=NC(=C1)C1=CC=CC=C1)C PEAHOTHJNQUEHV-YGBDOONVSA-N 0.000 claims 1
- LBUCTRFPQKCUEE-SAGXTMGHSA-N (2R,3S,4S,5S,6R)-2-(hydroxymethyl)-6-[(R)-hydroxy-[2-methyl-4-(4-piperidin-3-yltriazol-1-yl)phenyl]methyl]oxane-3,4,5-triol Chemical compound O[C@@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)C1=C(C=C(C=C1)N1N=NC(=C1)C1CNCCC1)C LBUCTRFPQKCUEE-SAGXTMGHSA-N 0.000 claims 1
- XPJSMVSHCOSLJG-COXXTLHVSA-N (2R,3S,4S,5S,6R)-2-(hydroxymethyl)-6-[(R)-hydroxy-[2-methyl-4-(4-pyridin-2-yltriazol-1-yl)phenyl]methyl]oxane-3,4,5-triol Chemical compound O[C@@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)C1=C(C=C(C=C1)N1N=NC(=C1)C1=NC=CC=C1)C XPJSMVSHCOSLJG-COXXTLHVSA-N 0.000 claims 1
- CYVDRLFXEZLSLV-COXXTLHVSA-N (2R,3S,4S,5S,6R)-2-(hydroxymethyl)-6-[(R)-hydroxy-[2-methyl-4-(4-pyridin-3-yltriazol-1-yl)phenyl]methyl]oxane-3,4,5-triol Chemical compound O[C@@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)C1=C(C=C(C=C1)N1N=NC(=C1)C=1C=NC=CC=1)C CYVDRLFXEZLSLV-COXXTLHVSA-N 0.000 claims 1
- VGBROTHFDPYTKQ-VWJUVAHCSA-N (2R,3S,4S,5S,6R)-2-(hydroxymethyl)-6-[(R)-hydroxy-[2-methyl-4-[2-(methylamino)pyridin-4-yl]phenyl]methyl]oxane-3,4,5-triol Chemical compound O[C@@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)C1=C(C=C(C=C1)C1=CC(=NC=C1)NC)C VGBROTHFDPYTKQ-VWJUVAHCSA-N 0.000 claims 1
- XCMVJWPLTYWEDN-QONVVCGCSA-N (2R,3S,4S,5S,6R)-2-(hydroxymethyl)-6-[(R)-hydroxy-[2-methyl-4-[3-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]oxane-3,4,5-triol Chemical compound O[C@@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)C1=C(C=C(C=C1)C1=CC(=CC=C1)C1=NN=NN1)C XCMVJWPLTYWEDN-QONVVCGCSA-N 0.000 claims 1
- OYVUQGGMIIRQFT-IZMFDJJNSA-N (2R,3S,4S,5S,6R)-2-[(R)-(4-azido-2-methylphenyl)-hydroxymethyl]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound N(=[N+]=[N-])C1=CC(=C(C=C1)[C@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)O)C OYVUQGGMIIRQFT-IZMFDJJNSA-N 0.000 claims 1
- JMAAVUWHXCRGNT-YGBDOONVSA-N (2R,3S,4S,5S,6R)-2-[(R)-[4-(1-aminoisoquinolin-5-yl)-2-methylphenyl]-hydroxymethyl]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound NC1=NC=CC2=C(C=CC=C12)C1=CC(=C(C=C1)[C@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)O)C JMAAVUWHXCRGNT-YGBDOONVSA-N 0.000 claims 1
- XJLCQOFRXPYLTB-YGBDOONVSA-N (2R,3S,4S,5S,6R)-2-[(R)-[4-(1-aminoisoquinolin-7-yl)-2-methylphenyl]-hydroxymethyl]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound NC1=NC=CC2=CC=C(C=C12)C1=CC(=C(C=C1)[C@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)O)C XJLCQOFRXPYLTB-YGBDOONVSA-N 0.000 claims 1
- DZRKNIAMUSCTEN-QONVVCGCSA-N (2R,3S,4S,5S,6R)-2-[(R)-[4-(3-amino-1,2-benzoxazol-5-yl)-2-methylphenyl]-hydroxymethyl]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound NC1=NOC2=C1C=C(C=C2)C1=CC(=C(C=C1)[C@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)O)C DZRKNIAMUSCTEN-QONVVCGCSA-N 0.000 claims 1
- AGCZMIRRKWAEEV-VWJUVAHCSA-N (2R,3S,4S,5S,6R)-2-[(R)-[4-(3-amino-1H-indazol-7-yl)-2-methylphenyl]-hydroxymethyl]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound NC1=NNC2=C(C=CC=C12)C1=CC(=C(C=C1)[C@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)O)C AGCZMIRRKWAEEV-VWJUVAHCSA-N 0.000 claims 1
- KVAAZTFFEHHECZ-COXXTLHVSA-N (2R,3S,4S,5S,6R)-2-[(R)-[4-(3H-benzimidazol-5-yl)-2-methylphenyl]-hydroxymethyl]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound N1=CNC2=C1C=CC(=C2)C1=CC(=C(C=C1)[C@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)O)C KVAAZTFFEHHECZ-COXXTLHVSA-N 0.000 claims 1
- XPBRQDSSRZGYFF-WABZNMTCSA-N (2R,3S,4S,5S,6R)-2-[(R)-[4-[2-(2-chloropyridin-4-yl)pyridin-4-yl]-2-methylphenyl]-hydroxymethyl]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound ClC1=NC=CC(=C1)C1=NC=CC(=C1)C1=CC(=C(C=C1)[C@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)O)C XPBRQDSSRZGYFF-WABZNMTCSA-N 0.000 claims 1
- FOWWFTZBDSDPIR-ICBQOUSBSA-N (2R,3S,4S,5S,6R)-2-[(R)-[4-[2-(dimethylamino)pyridin-4-yl]-2-methylphenyl]-hydroxymethyl]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound CN(C1=NC=CC(=C1)C1=CC(=C(C=C1)[C@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)O)C)C FOWWFTZBDSDPIR-ICBQOUSBSA-N 0.000 claims 1
- GZJSNRRKWWXBAD-ICBQOUSBSA-N (2R,3S,4S,5S,6R)-2-[(R)-hydroxy-(4-imidazo[1,2-a]pyridin-2-yl-2-methylphenyl)methyl]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)C1=C(C=C(C=C1)C=1N=C2N(C=CC=C2)C=1)C GZJSNRRKWWXBAD-ICBQOUSBSA-N 0.000 claims 1
- UXVMTOZAOWRMRY-LAAXVVMPSA-N (2R,3S,4S,5S,6R)-2-[(R)-hydroxy-(4-isoquinolin-5-yl-2-methylphenyl)methyl]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)C1=C(C=C(C=C1)C1=C2C=CN=CC2=CC=C1)C UXVMTOZAOWRMRY-LAAXVVMPSA-N 0.000 claims 1
- VHSTWZOYXHPXAB-LAAXVVMPSA-N (2R,3S,4S,5S,6R)-2-[(R)-hydroxy-(4-isoquinolin-6-yl-2-methylphenyl)methyl]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)C1=C(C=C(C=C1)C=1C=C2C=CN=CC2=CC=1)C VHSTWZOYXHPXAB-LAAXVVMPSA-N 0.000 claims 1
- YTIDDZGQMWKPPJ-LAAXVVMPSA-N (2R,3S,4S,5S,6R)-2-[(R)-hydroxy-(4-isoquinolin-7-yl-2-methylphenyl)methyl]-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)C1=C(C=C(C=C1)C1=CC=C2C=CN=CC2=C1)C YTIDDZGQMWKPPJ-LAAXVVMPSA-N 0.000 claims 1
- DNXMEIJSSQULQQ-YGBDOONVSA-N 3-[1-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]triazol-4-yl]benzoic acid Chemical compound O[C@H](C1=C(C=C(C=C1)N1N=NC(=C1)C=1C=C(C(=O)O)C=CC=1)C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO DNXMEIJSSQULQQ-YGBDOONVSA-N 0.000 claims 1
- YUFRPAWWVXMZKD-QONVVCGCSA-N 3-[3-chloro-4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]phenyl]-N-methylbenzamide Chemical compound ClC=1C=C(C=CC=1[C@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)O)C1=CC(=CC=C1)C(=O)NC YUFRPAWWVXMZKD-QONVVCGCSA-N 0.000 claims 1
- LXHAPBHATOIYMM-COXXTLHVSA-N 3-[4-[(R)-amino-[(2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-N-methylbenzamide Chemical compound N[C@H](C1=C(C=C(C=C1)C1=CC(=CC=C1)C(=O)NC)C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO LXHAPBHATOIYMM-COXXTLHVSA-N 0.000 claims 1
- ZQWGQHKPEADKPA-ICBQOUSBSA-N 3-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methyl-2-nitrophenoxy]benzonitrile Chemical compound O[C@H](C1=C(C(=C(OC=2C=C(C#N)C=CC=2)C=C1)[N+](=O)[O-])C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO ZQWGQHKPEADKPA-ICBQOUSBSA-N 0.000 claims 1
- VOBFHPHBWRQCQL-YGBDOONVSA-N 3-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-N,N-dimethylbenzamide Chemical compound O[C@H](C1=CC=C(C=C1C)C1=CC(=CC=C1)C(=O)N(C)C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO VOBFHPHBWRQCQL-YGBDOONVSA-N 0.000 claims 1
- BQKOPRXLZXVLEL-COXXTLHVSA-N 3-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-N-methylbenzamide Chemical compound O[C@H](C1=C(C=C(C=C1)C=1C=C(C(=O)NC)C=CC=1)C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO BQKOPRXLZXVLEL-COXXTLHVSA-N 0.000 claims 1
- CISCSVWAMMNQGS-COXXTLHVSA-N 3-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]benzonitrile Chemical compound O[C@H](C1=C(C=C(C=C1)C1=CC(=CC=C1)C#N)C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO CISCSVWAMMNQGS-COXXTLHVSA-N 0.000 claims 1
- KOOGCRKRQNOZBW-QONVVCGCSA-N 3-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]phenyl]-N-methylbenzamide Chemical compound O[C@H](C1=CC=C(C=C1)C1=CC(=CC=C1)C(=O)NC)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO KOOGCRKRQNOZBW-QONVVCGCSA-N 0.000 claims 1
- AZGLSCRTGDEBPU-OGVIVNNGSA-N 3-[4-[(R)-methoxy-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-N-methylbenzamide Chemical compound CO[C@H](C1=C(C=C(C=C1)C1=CC(=CC=C1)C(=O)NC)C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO AZGLSCRTGDEBPU-OGVIVNNGSA-N 0.000 claims 1
- RBEAYUJGRSFBAX-XHYRXIGBSA-N 3-[4-[(S)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-(trifluoromethyl)phenyl]-N-methylbenzamide Chemical compound O[C@@H](C1=C(C=C(C=C1)C1=CC(=CC=C1)C(=O)NC)C(F)(F)F)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO RBEAYUJGRSFBAX-XHYRXIGBSA-N 0.000 claims 1
- KOOGCRKRQNOZBW-XHYRXIGBSA-N 3-[4-[(S)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]phenyl]-N-methylbenzamide Chemical compound O[C@@H](C1=CC=C(C=C1)C1=CC(=CC=C1)C(=O)NC)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO KOOGCRKRQNOZBW-XHYRXIGBSA-N 0.000 claims 1
- QAYHHFFKGKYORI-SLHNCBLASA-N 3-[4-[difluoro-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-N-methylbenzamide Chemical compound FC(C1=C(C=C(C=C1)C1=CC(=CC=C1)C(=O)NC)C)([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)F QAYHHFFKGKYORI-SLHNCBLASA-N 0.000 claims 1
- VPQUEVVDCLWQHW-GQTGZYIQSA-N 3-[4-[methoxy-[(2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-2-methylphenyl]-N-methylbenzamide Chemical compound COC(C1=CC(=C(C=C1)C1=CC(=CC=C1)C(=O)NC)C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO VPQUEVVDCLWQHW-GQTGZYIQSA-N 0.000 claims 1
- RIZWZSUMKJODAU-YGBDOONVSA-N 3-cyano-5-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-N-methylbenzamide Chemical compound C(#N)C=1C=C(C=C(C=1)C1=CC=C(C(=C1)C)[C@H]([C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO)O)C(=O)NC RIZWZSUMKJODAU-YGBDOONVSA-N 0.000 claims 1
- CHPPOFBCSOYKRL-COXXTLHVSA-N 4-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-2,3-dihydroisoindol-1-one Chemical compound O[C@H](C1=C(C=C(C=C1)C1=C2CNC(C2=CC=C1)=O)C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO CHPPOFBCSOYKRL-COXXTLHVSA-N 0.000 claims 1
- IHLANBYQSJKTFQ-COXXTLHVSA-N 4-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]benzonitrile Chemical compound O[C@H](C1=C(C=C(C=C1)C1=CC=C(C=C1)C#N)C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO IHLANBYQSJKTFQ-COXXTLHVSA-N 0.000 claims 1
- BKTJWUBEKHGIJC-YGBDOONVSA-N 5-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-1-N,3-N-dimethylbenzene-1,3-dicarboxamide Chemical compound O[C@H](C1=C(C=C(C=C1)C1=CC(=CC(=C1)C(=O)NC)C(=O)NC)C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO BKTJWUBEKHGIJC-YGBDOONVSA-N 0.000 claims 1
- LRQKTUASLOZAGT-YGBDOONVSA-N 5-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-2H-isoquinolin-1-one Chemical compound O[C@H](C1=C(C=C(C=C1)C1=C2C=CNC(C2=CC=C1)=O)C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO LRQKTUASLOZAGT-YGBDOONVSA-N 0.000 claims 1
- JMGVTUNAQJFHFV-QONVVCGCSA-N 5-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-N-methylpyridine-3-carboxamide Chemical compound O[C@H](C1=C(C=C(C=C1)C=1C=NC=C(C(=O)NC)C=1)C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO JMGVTUNAQJFHFV-QONVVCGCSA-N 0.000 claims 1
- LHWVMHLQKVDNMJ-YGBDOONVSA-N 5-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-N-propan-2-ylpyridine-3-carboxamide Chemical compound O[C@H](C1=C(C=C(C=C1)C=1C=NC=C(C(=O)NC(C)C)C=1)C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO LHWVMHLQKVDNMJ-YGBDOONVSA-N 0.000 claims 1
- WMWMDJRAXQZQKE-HMSXXHTOSA-N 5-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]pyridine-3-carboxylic acid Chemical compound O[C@H](C1=C(C=C(C=C1)C=1C=NC=C(C(=O)O)C=1)C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO WMWMDJRAXQZQKE-HMSXXHTOSA-N 0.000 claims 1
- UKLNSMLYILMQOL-RLVGIJBXSA-N 6-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-1H-thieno[3,2-d]pyrimidine-2,4-dione Chemical compound O[C@H](C1=C(C=C(C=C1)C1=CC=2NC(NC(C=2S1)=O)=O)C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO UKLNSMLYILMQOL-RLVGIJBXSA-N 0.000 claims 1
- SLXDPKARMDUOJA-COXXTLHVSA-N 6-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-2,3-dihydroisoindol-1-one Chemical compound O[C@H](C1=C(C=C(C=C1)C1=CC=C2CNC(C2=C1)=O)C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO SLXDPKARMDUOJA-COXXTLHVSA-N 0.000 claims 1
- YHYWHAFCLUSLBS-YKHMXAMPSA-N 7-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3,5-dimethylphenyl]-2H-isoquinolin-1-one Chemical compound O[C@H](C1=C(C=C(C=C1C)C1=CC=C2C=CNC(C2=C1)=O)C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO YHYWHAFCLUSLBS-YKHMXAMPSA-N 0.000 claims 1
- WTOPHPRTQAIFQH-COXXTLHVSA-N 7-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-(trifluoromethyl)phenyl]-3,4-dihydro-2H-isoquinolin-1-one Chemical compound O[C@H](C1=C(C=C(C=C1)C1=CC=C2CCNC(C2=C1)=O)C(F)(F)F)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO WTOPHPRTQAIFQH-COXXTLHVSA-N 0.000 claims 1
- MTOSTFRWLUDNQB-LAAXVVMPSA-N 7-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-2-methyl-3,4-dihydroisoquinolin-1-one Chemical compound O[C@H](C1=C(C=C(C=C1)C1=CC=C2CCN(C(C2=C1)=O)C)C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO MTOSTFRWLUDNQB-LAAXVVMPSA-N 0.000 claims 1
- RDECCMMREUFDLH-LAAXVVMPSA-N 7-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-2-methylisoquinolin-1-one Chemical compound O[C@H](C1=C(C=C(C=C1)C1=CC=C2C=CN(C(C2=C1)=O)C)C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO RDECCMMREUFDLH-LAAXVVMPSA-N 0.000 claims 1
- DVIRRRQNMINJAC-MBJZRRMBSA-N 7-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-2-propan-2-yl-3,4-dihydroisoquinolin-1-one Chemical compound O[C@H](C1=C(C=C(C=C1)C1=CC=C2CCN(C(C2=C1)=O)C(C)C)C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO DVIRRRQNMINJAC-MBJZRRMBSA-N 0.000 claims 1
- YXCCASZYDZARSN-MBJZRRMBSA-N 7-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-2-propan-2-ylisoquinolin-1-one Chemical compound O[C@H](C1=C(C=C(C=C1)C1=CC=C2C=CN(C(C2=C1)=O)C(C)C)C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO YXCCASZYDZARSN-MBJZRRMBSA-N 0.000 claims 1
- ZPUAZKGNGMDQNR-YGBDOONVSA-N 7-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-2H-isoquinolin-1-one Chemical compound O[C@H](C1=C(C=C(C=C1)C1=CC=C2C=CNC(C2=C1)=O)C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO ZPUAZKGNGMDQNR-YGBDOONVSA-N 0.000 claims 1
- JEGXNQLNJFZGCZ-YGBDOONVSA-N 7-[4-[(R)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-methylphenyl]-3,4-dihydro-2H-isoquinolin-1-one Chemical compound O[C@H](C1=C(C=C(C=C1)C1=CC=C2CCNC(C2=C1)=O)C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO JEGXNQLNJFZGCZ-YGBDOONVSA-N 0.000 claims 1
- YHYWHAFCLUSLBS-LANYJBNVSA-N 7-[4-[(S)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3,5-dimethylphenyl]-2H-isoquinolin-1-one Chemical compound O[C@@H](C1=C(C=C(C=C1C)C1=CC=C2C=CNC(C2=C1)=O)C)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO YHYWHAFCLUSLBS-LANYJBNVSA-N 0.000 claims 1
- WTOPHPRTQAIFQH-ZWJPJJENSA-N 7-[4-[(S)-hydroxy-[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]-3-(trifluoromethyl)phenyl]-3,4-dihydro-2H-isoquinolin-1-one Chemical compound O[C@@H](C1=C(C=C(C=C1)C1=CC=C2CCNC(C2=C1)=O)C(F)(F)F)[C@H]1O[C@@H]([C@H]([C@@H]([C@@H]1O)O)O)CO WTOPHPRTQAIFQH-ZWJPJJENSA-N 0.000 claims 1
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- 101100294111 Caenorhabditis elegans nhr-44 gene Proteins 0.000 claims 1
- JTPUMZTWMWIVPA-UHFFFAOYSA-O Isopropamide Chemical compound C=1C=CC=CC=1C(C(N)=O)(CC[N+](C)(C(C)C)C(C)C)C1=CC=CC=C1 JTPUMZTWMWIVPA-UHFFFAOYSA-O 0.000 claims 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 230000001668 ameliorated effect Effects 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 125000004438 haloalkoxy group Chemical group 0.000 claims 1
- 230000005764 inhibitory process Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000000306 recurrent effect Effects 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
- 0 Cc1c([C@](C(C(C2O)O)OC(CO)C2O)O)ccc(-[n]2nnc(*)c2)c1 Chemical compound Cc1c([C@](C(C(C2O)O)OC(CO)C2O)O)ccc(-[n]2nnc(*)c2)c1 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662307078P | 2016-03-11 | 2016-03-11 | |
| US62/307,078 | 2016-03-11 | ||
| PCT/US2017/021983 WO2017156508A1 (en) | 2016-03-11 | 2017-03-11 | C-glycoside compounds useful for treating disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019508504A JP2019508504A (ja) | 2019-03-28 |
| JP2019508504A5 true JP2019508504A5 (https=) | 2020-04-23 |
Family
ID=59789872
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018567029A Pending JP2019508504A (ja) | 2016-03-11 | 2017-03-11 | 疾病の処置に有用なｃ−グリコシド化合物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20200002303A1 (https=) |
| EP (1) | EP3426260A4 (https=) |
| JP (1) | JP2019508504A (https=) |
| CN (1) | CN108883122A (https=) |
| WO (1) | WO2017156508A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017238392A1 (en) | 2016-03-23 | 2018-09-27 | Fimbrion Therapeutics, Inc. | Mannose-derived antagonists of FimH useful for treating disease |
| RS63712B1 (sr) | 2018-07-10 | 2022-11-30 | Glaxosmithkline Ip Dev Ltd | Jedinjenja c-manozida korisna za tretman infekcija urinarnog trakta |
| CA3138394A1 (en) * | 2019-05-07 | 2020-11-12 | Glaxosmithkline Intellectual Property Development Limited | Novel compounds |
| WO2020254369A1 (en) | 2019-06-19 | 2020-12-24 | Glaxosmithkline Intellectual Property Development Limited | Substituted biphenyl or phenylheteroaryl-mannosides as antagonists of fimh |
| JP7736678B2 (ja) * | 2019-10-16 | 2025-09-09 | ケモセントリックス，インコーポレイティド | Ｐｄ－ｌ１疾患の処置のためのヘテロアリール－ビフェニルアミド |
| WO2021197363A1 (zh) * | 2020-03-31 | 2021-10-07 | 苏州大学 | 2-炔基甘露糖衍生物及其应用 |
| CN113582956A (zh) * | 2020-04-30 | 2021-11-02 | 华东师范大学 | 含硫芳基碳苷类化合物及其合成方法和应用 |
| CN115197185B (zh) * | 2021-04-12 | 2024-03-22 | 中国科学院大连化学物理研究所 | 一种过渡金属催化的吡喃糖苷衍生物的制备方法 |
| CN115656356B (zh) * | 2022-09-30 | 2025-03-21 | 南京正济医药研究有限公司 | 4-羟基-7-苯氧基异喹啉-3-甲酸甲酯及其有关物质的测定方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2672820B1 (en) * | 2011-02-07 | 2019-04-17 | The Washington University | Mannoside compounds and methods of use thereof |
| US20150197536A1 (en) * | 2012-07-28 | 2015-07-16 | The Regents Of The University Of Colorado, A Body Corporate | Compounds reducing the production of sorbitol in the eye and methods of using the same |
| MX2015012472A (es) * | 2013-03-12 | 2016-02-10 | Vertex Pharma | Derivados de manosa para el tratamiento de infecciones bacterianas. |
| CN105682665A (zh) * | 2013-05-30 | 2016-06-15 | 华盛顿大学 | 用于治疗细菌性感染的化合物和方法 |
-
2017
- 2017-03-11 JP JP2018567029A patent/JP2019508504A/ja active Pending
- 2017-03-11 WO PCT/US2017/021983 patent/WO2017156508A1/en not_active Ceased
- 2017-03-11 EP EP17764270.9A patent/EP3426260A4/en not_active Withdrawn
- 2017-03-11 CN CN201780020502.2A patent/CN108883122A/zh active Pending
- 2017-03-11 US US16/084,177 patent/US20200002303A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019508504A5 (https=) | ||
| EP3658538B1 (en) | Compounds and compositions for treating conditions associated with nlrp activity | |
| JP5735986B2 (ja) | 新規抗マラリア剤 | |
| CN104066731B (zh) | 可用作sgc刺激剂的2-苄基、3-(嘧啶-2-基)取代的吡唑类 | |
| CA2339961C (en) | Isoquinoline derivatives with angiogenesis inhibiting activity | |
| JP5592388B2 (ja) | 疼痛治療用のｐ２ｘ３受容体アンタゴニスト技術分野 | |
| CN106061480B (zh) | 治疗性抑制性化合物 | |
| TWI567067B (zh) | ＴｒＫ抑制化合物 | |
| KR101666729B1 (ko) | Mgat2 억제제로서의 아릴 디히드로피리디논 및 피페리디논 | |
| RU2018131440A (ru) | Антагонисты FimH, являющиеся производными маннозы, пригодные для лечения заболевания | |
| JP2019509315A5 (https=) | ||
| US20220267276A1 (en) | Nlrp modulators | |
| CA2412968A1 (en) | Substituted pyridines as selective cyclooxygenase-2 inhibitors | |
| KR20100041799A (ko) | 신규한 ｈｉｖ 역전사효소 억제제 | |
| US20140171446A1 (en) | Compounds for inflammation and immune-related uses | |
| JP2022528042A (ja) | アミド類化合物の調製方法及びその医薬分野の使用 | |
| JP6413032B2 (ja) | 新規ｄｇａｔ２阻害剤 | |
| JP2015500824A (ja) | 新規ピロール誘導体 | |
| JP2020532551A (ja) | Ｒｈｏ関連コイルドコイルキナーゼ（ＲＯＣＫ）阻害剤としてのビニルヘテロ環 | |
| US20210395241A1 (en) | Nlrp modulators | |
| JP2008543848A (ja) | ケモカイン受容体結合化合物 | |
| JP7399898B2 (ja) | ＰｑｓＲインバースアゴニスト | |
| WO2023222115A1 (zh) | 一种羟基酰胺类衍生物及其应用 | |
| US8772304B2 (en) | Benzimidazole inhibitors of leukotriene production | |
| JP6219817B2 (ja) | フェニルキサンテン誘導体 |